Dioxane

Dioxane

SCHEMBL30380

C1COCCO1.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Dioxane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dioxane SCHEMBL19124170 1.00
Hydrochloric Acid SCHEMBL31664298 1.00 TTR (0.86)
Dioxane SCHEMBL25293907 1.00 TTR (0.86)
Dioxane SCHEMBL23466883 1.00 TTR (0.86)
Dioxane SCHEMBL28467529 0.94
Dioxane SCHEMBL28825140 0.94
Dioxane SCHEMBL1227663 0.94
Dioxane SCHEMBL6954886 0.94
Oxirane SCHEMBL9903963 0.93
Oxirane SCHEMBL4815843 0.93

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 13663 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121248582-B CDK12/PARP double-target inhibitor and preparation method and application thereof SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2026-05-26 CN claimed
US-12637469-B2 1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2026-05-26 US claimed
CN-122071449-A Substituted biphenyl compounds and application thereof in synthesis of cola pyrroside 北京凯因格领生物技术有限公司 2026-05-22 CN claimed
EP-3797103-B1 A NOVEL PROCESS FOR THE PREPARATION OF ANTHRANILIC DIAMIDES PI INDUSTRIES LTD (IN) 2026-04-08 EP claimed
EP-4712957-A2 ISOANDROGRAPHOLIDE ANALOGS AND METHOD FOR TREATMENT USING THE SAME Enveda Therapeutics, Inc. (US) 2026-03-25 EP claimed
CN-119606872-B Multifunctional hydrogel and application thereof 山东第二医科大学 2025-06-13 CN claimed
CN-115960346-B Amphiphilic polymer with retinol derivative as hydrophobic chain 中国药科大学 2025-05-27 CN claimed
CN-120004919-A Synthesis method and application of N-heterocyclic carbene compound based on functionalized porphyrin 西北大学 2025-05-16 CN claimed
CN-119954866-A Pentafluoroalkoxy ring preparation method of triphosphazene 安徽金禾合成材料研究院有限公司 2025-05-09 CN claimed
CN-119930591-A STING degradation agent with nitrogenous ring derivative as Linker, and synthetic method and application thereof 海南大学 2025-05-06 CN claimed
US-7163917-B2 Synthesis method of alanylglutamine ZHAO YUFEN 2007-01-16 US claimed
US-20050233977-A1 Process of producing ala-gln dipeptide ZHAO YUFEN 2005-10-20 US claimed
CN-1467220-A Tripeptide analogs, preparation method thereof, pharmaceutical compositions containing the same and application thereof 中国人民解放军军事医学科学院毒物药 2004-01-14 CN claimed
CN-1467219-A Pentapeptide analogues, their preparation and their use 中国人民解放军军事医学科学院毒物药 2004-01-14 CN claimed
EP-0376870-A1 A new organosilylpolyphosphoric reagent, its preparation and application to the process of synthesis of 3-carboxyquinolones or azaquinolones and their salts CENTRO MARGA PARA LA INVESTIGACION S.A. (ES) 1990-07-04 EP claimed
EP-0356366-A1 A process for the preparation of N-sulfamyl-propionamidine derivatives CENTRO MARGA PARA LA INVESTIGACION S.A. (ES) 1990-02-28 EP claimed
EP-0126942-B1 PREPARATION PROCESS OF ACEMETACIN Troponwerke GmbH &amp; Co. KG (DE) 1987-09-30 EP claimed
US-4603210-A Preparation process of acemetacin TROPONWERKE GMBH & CO. KG. (DE) 1986-07-29 US claimed
EP-0126942-A1 Preparation process of acemetacin Troponwerke GmbH &amp; Co. KG (DE) 1984-12-05 EP claimed
US-4330466-A Process for the production of cholecystokinin-pancreozymin C-terminal peptide amide sulfate esters AMANO PHARMACEUTICAL CO., LTD. (JP) 1982-05-18 US claimed